Macrogenics Inc

MGNX NASDAQ Santé & Biotech États-Unis US5560991094
4.25 $
1.19 %

MacroGenics développe des anticorps monoclonaux pour le traitement des maladies cancéreuses et auto-immunes.

Price history of Macrogenics Inc
Price history of Macrogenics Inc

Performance & Momentum

6 Months
1 Year
3 Years
5 Years 84.27 %

Similar stocks to Macrogenics Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone